Skip to main content

Purdue Pharma Faces New York Lawsuit On Opioid Epidemic

Purdue Pharma Faces New York Lawsuit On Opioid Epidemic

Purdue Pharma Faces New York Lawsuit On Opioid Epidemic

Introduction

The owners of Purdue Pharma LP faces New York lawsuit claiming that they triggered the U.S. opioid epidemic. The state judge denied the defendant's request to dismiss the lawsuit filed by several counties in New York.

According to the New York Government attorney, the ruling in Suffolk County is the first by any court denying a motion by the Sacklers to throw out a suit by a state or county and allowing for pretrial fact-finding to proceed against the individual defendants.

Sackler family was targeted by state and local governments for the marketing of Oxycontin painkiller, to recover the social costs of opioid addiction, such as payments for opioid prescriptions and Medicaid benefits that wouldn’t have been approved if the risks had been known.

There are 2,000 suits against opioid makers consolidated in the federal court of Ohio and other cases are pending in state courts. In March, New York Attorney General Letitia James sued Sacklers over the addiction epidemic two days after Purdue agreed to pay $270 million to settle similar claims by Oklahoma. 

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!